Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Wockhardt

Sector: Healthcare | Industry: Drugs & Pharma
R 259.20 3.30  | 1.29% -47.14% - 2,868.59
NSE Price: Oct 17, 16:00 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 17, 16:00 259.20 3.30 1.29% 255.15 255.90 441,295 254.10 - 261.50
BSE Oct 17, 2019 259.05 3.70 1.45% 257.00 255.35 39,147 254.35 - 261.40
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,194,138 P/B: 1.10 NSE Code: WOCKPHARMA
52-Week Range: R 230.15 - 578.45 Dividend Yield: 0.00% BSE Code: 532300
TTM EPS: R -13.85 Book Value: R 235.31 Face Value: R 5
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Wockhardt -50.46 -19.37 -27.14 -47.14 -33.01 -18.69 3.01
S&P BSE Small Cap -12.19 0.46 -5.85 -9.51 -0.50 4.60 5.21
S&P BSE Healthcare -10.20 -2.68 -4.93 -14.60 -7.95 -1.47 10.83
Company's return has been calculated on basis of NSE's price.
As on Oct 17, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 5.63 -2.26 -2.95
Net Profit 67.51 -195.14 -176.21
EPS 68.03 -191.84 -177.24
Book Value -6.18 -11.03 -4.14
Average
Operating Margin 3.14 3.14 7.86
Net Margin -5.18 -9.04 -2.49
Return on Networth -7.94 -12.06 -3.32
Return on Investment -0.56 -2.12 2.35
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -11.85 -14.35 -11.85
Operating Profit -21.30 303.96 -21.30
Net Profit -165.32 61.20 -165.32
EPS -210.78 47.84 -210.78
TTM
Revenue -3.48 -0.98 -3.48
Operating Profit 27.65 6.20 27.65
Net Profit 26.85 47.06 26.85
EPS 21.20 46.19 21.20
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Wockhardt 2,868.59 4,013.78 -158.48 -3.89 -7.94 1.10 -
Astrazeneca Pharma India 5,748.75 771.42 69.56 8.84 20.03 17.95 82.64
Eris Lifesciences 5,689.19 1,005.70 303.64 29.29 28.96 4.61 18.74
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 10, 2019 Manas Datta  Buy ESOP 2,000 242.75 4.86
Jun 04, 2019 Deboiina Partap  Buy ESOP 2,000 405.75 8.12
Jun 04, 2019 Mahesh Patel  Buy ESOP 6,000 405.75 24.35
Jun 04, 2019 Sunil Khera  Buy ESOP 10,000 405.75 40.58
May 13, 2019 Mahesh Ptel  Sell Market 2,000 358.60 7.17
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Motilal Oswal Mutual Fund 0.001 - - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Wockhardt Ltd.

Address: Wockhardt Research Centre, D-4, M.i.d.c, Chikalthana, Aurangabad, Maharashtra - 431006 | Phone: 91-240-6632222 | Fax: 91-240-2489219

Email: [email protected]

Website: www.wockhardt.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
1.32
Piotroski F-Score
6
Modified C-Score
2
5-Years Price to Earnings
Not applicable
5-Years Price to Book
1.10
Earnings Yield
EBIT / Enterprise value
-0.26%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,299.25 +4.57%
Caplin Point Laboratories R394.45 -2.30%
Dishman Carbogen Amcis R155.55 -1.24%
Eris Lifesciences R416.05 -0.22%
FDC R161.35 +0.62%
JB Chemicals & Pharma R359.25 +0.45%
Laurus Labs R310.25 -0.80%
Strides Pharma Science R353.85 +0.78%
Sun Pharma Adv. Research R130.70 +1.32%
Suven Life Sciences R264.80 +1.83%
As on Oct 17, 16:00